Reference
1. Xiao P, Guo T, Luo Y, Zhang M, Yin R. Real-world data of 14 cases of
brain metastases from gestational trophoblastic neoplasia and a
literature review. Archives of gynecology and obstetrics. 2021 Sep 20.
2. Maestá I, de Freitas Segalla Moreira M, Rezende-Filho J, Bianconi MI,
Jankilevich G, Otero S, et al. Outcomes in the management of high-risk
gestational trophoblastic neoplasia in trophoblastic disease centers in
South America. International journal of gynecological cancer : official
journal of the International Gynecological Cancer Society. 2020
Sep;30(9):1366-71.
3. Lurain JR. Gestational trophoblastic disease I: epidemiology,
pathology, clinical presentation and diagnosis of gestational
trophoblastic disease, and management of hydatidiform mole. American
journal of obstetrics and gynecology. 2010 Dec;203(6):531-9.
4. Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease.
Lancet (London, England). 2010 Aug 28;376(9742):717-29.
5. Kong Y, Yang J, Jiang F, Zhao J, Ren T, Li J, et al. Clinical
characteristics and prognosis of ultra high-risk gestational
trophoblastic neoplasia patients: A retrospective cohort study.
Gynecologic oncology. 2017 Jul;146(1):81-6.
6. Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, et
al. Diagnosis and management of gestational trophoblastic disease: 2021
update. International journal of gynaecology and obstetrics: the
official organ of the International Federation of Gynaecology and
Obstetrics. 2021 Oct;155 Suppl 1:86-93.
7. Crawford RA, Newlands E, Rustin GJ, Holden L, A’Hern R, Bagshawe KD.
Gestational trophoblastic disease with liver metastases: the Charing
Cross experience. British journal of obstetrics and gynaecology. 1997
Jan;104(1):105-9.
8. Ghorani E, Kaur B, Fisher RA, Short D, Joneborg U, Carlson JW, et al.
Pembrolizumab is effective for drug-resistant gestational trophoblastic
neoplasia. Lancet (London, England). 2017 Nov 25;390(10110):2343-5.
9. Zong L, Yang J, Wang X, Kong Y, Ren T, Zhao J, et al. Management and
prognosis of patients with liver metastases from gestational
trophoblastic neoplasia: a retrospective cohort study. Cancer management
and research. 2018;10:557-63.
10. Xiao C, Yang J, Zhao J, Ren T, Feng F, Wan X, et al. Management and
prognosis of patients with brain metastasis from gestational
trophoblastic neoplasia: a 24-year experience in Peking union medical
college hospital. BMC cancer. 2015 Apr 28;15:318.
11. Savage P, Kelpanides I, Tuthill M, Short D, Seckl MJ. Brain
metastases in gestational trophoblast neoplasia: an update on incidence,
management and outcome. Gynecologic oncology. 2015 Apr;137(1):73-6.
12. Gavanier D, Leport H, Massardier J, Abbas F, Schott AM, Hajri T, et
al. Gestational trophoblastic neoplasia with brain metastasis at initial
presentation: a retrospective study. International journal of clinical
oncology. 2019 Feb;24(2):153-60.
13. Alazzam M, Tidy J, Osborne R, Coleman R, Hancock BW, Lawrie TA.
Chemotherapy for resistant or recurrent gestational trophoblastic
neoplasia. Cochrane Database Syst Rev. 2016 Jan 13;2016(1):Cd008891.
14. Soper JT. Gestational Trophoblastic Disease: Current Evaluation and
Management. Obstetrics and gynecology. 2021 Feb 1;137(2):355-70.
15. Newlands ES. The management of recurrent and drug-resistant
gestational trophoblastic neoplasia (GTN). Best practice & research
Clinical obstetrics & gynaecology. 2003 Dec;17(6):905-23.
16. Ahamed E, Short D, North B, Savage PM, Seckl MJ. Survival of women
with gestational trophoblastic neoplasia and liver metastases: is it
improving? The Journal of reproductive medicine. 2012
May-Jun;57(5-6):262-9.
17. Schechter NR, Mychalczak B, Jones W, Spriggs D. Prognosis of
patients treated with whole-brain radiation therapy for metastatic
gestational trophoblastic disease. Gynecologic oncology. 1998
Feb;68(2):183-92.
18. Newlands ES, Holden L, Seckl MJ, McNeish I, Strickland S, Rustin GJ.
Management of brain metastases in patients with high-risk gestational
trophoblastic tumors. The Journal of reproductive medicine. 2002
Jun;47(6):465-71.
19. Alifrangis C, Agarwal R, Short D, Fisher RA, Sebire NJ, Harvey R, et
al. EMA/CO for high-risk gestational trophoblastic neoplasia: good
outcomes with induction low-dose etoposide-cisplatin and genetic
analysis. Journal of clinical oncology : official journal of the
American Society of Clinical Oncology. 2013 Jan 10;31(2):280-6.
20. Bolze PA, Riedl C, Massardier J, Lotz JP, You B, Schott AM, et al.
Mortality rate of gestational trophoblastic neoplasia with a FIGO score
of ≥13. American journal of obstetrics and gynecology. 2016
Mar;214(3):390.e1-8.
21. Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK,
et al. Update on the diagnosis and management of gestational
trophoblastic disease. International journal of gynaecology and
obstetrics: the official organ of the International Federation of
Gynaecology and Obstetrics. 2018 Oct;143 Suppl 2:79-85.
22. Jorgensen K, Roychowdhury M, da Cunha G, Kim YB, Schorge JO. Stage
IV Gestational Choriocarcinoma Diagnosed in the Third Trimester.
Obstetrics and gynecology. 2019 Jan;133(1):163-6.
23. Li Y, Kong Y, Wan X, Feng F, Ren T, Zhao J, et al. Results with
Floxuridine, Actinomycin D, Etoposide, and Vincristine in Gestational
Trophoblastic Neoplasias with International Federation of Gynecology and
Obstetrics Scores ≥5. The oncologist. 2021 Dec;26(12):e2209-e16.
24. Lurain JR, Singh DK, Schink JC. Primary treatment of metastatic
high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
The Journal of reproductive medicine. 2006 Oct;51(10):767-72.
25. Jareemit N, Horowitz NS, Goldstein DP, Berkowitz RS, Elias KM. EMA
vs EMACO in the treatment of gestational trophoblastic neoplasia.
Gynecologic oncology. 2020 Jul;158(1):99-104.
26. Han SN, Amant F, Leunen K, Devi UK, Neven P, Vergote I. EP-EMA
regimen (etoposide and cisplatin with etoposide, methotrexate, and
dactinomycin) in a series of 18 women with gestational trophoblastic
neoplasia. International journal of gynecological cancer : official
journal of the International Gynecological Cancer Society. 2012
Jun;22(5):875-80.
27. Anantharaju AA, Pallavi VR, Bafna UD, Rathod PS, R VC, K S, et al.
Role of salvage therapy in chemo resistant or recurrent high-risk
gestational trophoblastic neoplasm. International journal of
gynecological cancer : official journal of the International
Gynecological Cancer Society. 2019 Mar;29(3):547-53.
28. Choi MC, Oh J, Lee C. Effective anti-programmed cell death 1
treatment for chemoresistant gestational trophoblastic neoplasia.
European journal of cancer (Oxford, England : 1990). 2019 Nov;121:94-7.
29. Sato A, Usui H, Shozu M. ABO blood type compatibility is not a risk
factor for gestational trophoblastic neoplasia development from
androgenetic complete hydatidiform moles. American journal of
reproductive immunology (New York, NY : 1989). 2020 Jun;83(6):e13237.
30. Soper JT, Spillman M, Sampson JH, Kirkpatrick JP, Wolf JK,
Clarke-Pearson DL. High-risk gestational trophoblastic neoplasia with
brain metastases: individualized multidisciplinary therapy in the
management of four patients. Gynecologic oncology. 2007
Mar;104(3):691-4.
31. Ngu SF, Ngan HYS. Surgery including fertility-sparing treatment of
GTD. Best practice & research Clinical obstetrics & gynaecology. 2021
Jul;74:97-108.
32. Khoo SK. Clinical aspects of gestational trophoblastic disease: a
review based partly on 25-year experience of a statewide registry. The
Australian & New Zealand journal of obstetrics & gynaecology. 2003
Aug;43(4):280-9.
33. Lurain JR, Singh DK, Schink JC. Role of surgery in the management of
high-risk gestational trophoblastic neoplasia. The Journal of
reproductive medicine. 2006 Oct;51(10):773-6.
34. Neubauer NL, Latif N, Kalakota K, Marymont M, Small W, Jr., Schink
JC, et al. Brain metastasis in gestational trophoblastic neoplasia: an
update. The Journal of reproductive medicine. 2012
Jul-Aug;57(7-8):288-92.